QQ客服 官方微博 反馈留言

浏览/检索结果: 共12条，第1-10条 帮助 限定条件 专题：中南大学    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Effect of gene polymorphims on the warfarin treatment at initial stage. 期刊论文 The pharmacogenomics journal, 2017, 卷号: 17, 期号: 1, 页码: 47-52 作者:  Liu, J.;  Jiang, H. H.;  Wu, D. K.;  Zhou, Y. X.;  Ye, H. M. 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/03 Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). 期刊论文 AUTOPHAGY, 2016, 卷号: 12, 期号: 1, 页码: 1-222 作者:  Klionsky, Daniel J.*;  Abdelmohsen, Kotb;  Abe, Akihisa;  Abedin, Md Joynal;  Abeliovich, Hagai 收藏  |  浏览/下载：91/0  |  提交时间：2019/12/03 LC3  autolysosome  autophagosome  chaperone-mediated autophagy  flux  lysosome  macroautophagy  phagophore  stress  vacuole   Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 期刊论文 Autophagy, 2016, 卷号: 12, 期号: 1, 页码: 1-222 作者:  Klionsky, Daniel J.*;  Abdelmohsen, Kotb;  Abe, Akihisa;  Abedin, Md Joynal;  Abeliovich, Hagai 收藏  |  浏览/下载：72/0  |  提交时间：2019/12/03 LC3  autolysosome  autophagosome  chaperone-mediated autophagy  flux  lysosome  macroautophagy  phagophore  stress  vacuole   Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015 期刊论文 LANCET, 2016, 卷号: 388, 期号: 10053, 页码: 1459-1544 作者:  Wang, Haidong;  Naghavi, Mohsen;  Allen, Christine;  Barber, Ryan M.;  Bhutta, Zulfiqar A. 收藏  |  浏览/下载：49/0  |  提交时间：2019/12/03 Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin 期刊论文 European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2015, 卷号: 34, 期号: 4, 页码: 737-744 作者:  Mei, Q.;  Ye, Y.;  Zhu, Y. -L.;  Cheng, J.;  Chang, X. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/03 Minimal Inhibitory Concentration  Fosfomycin  Plastic Ball  Mutant Prevention Concentration  Kill Study   Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. 期刊论文 The Lancet, 2015, 卷号: 386, 期号: 10009, 页码: 2145-2191 作者:  Murray, Christopher J. L.*;  Barber, Ryan M.;  Foreman, Kyle J.;  Ozgoren, Ayse Abbasoglu;  Abd-Allah, Foad 收藏  |  浏览/下载：47/0  |  提交时间：2019/12/03 Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013 期刊论文 The Lancet, 2015, 卷号: 386, 期号: 9995, 页码: 743-800 作者:  Vos, Theo*;  Barber, Ryan M.;  Bell, Brad;  Bertozzi-Villa, Amelia;  Biryukov, Stan 收藏  |  浏览/下载：44/0  |  提交时间：2019/12/03 Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. 期刊论文 The Lancet, 2015, 卷号: 386, 期号: 10010, 页码: 2287-2323 作者:  Forouzanfar, Mohammad H.;  Alexander, Lily;  Anderson, H. Ross;  Bachman, Victoria F.;  Biryukov, Stan 收藏  |  浏览/下载：33/0  |  提交时间：2019/12/03 Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802) 期刊论文 Annals of Oncology, 2015, 卷号: 26, 期号: 9, 页码: 1877-1883 作者:  Zhou, C.*;  Wu, Y. L.;  Chen, G.;  Feng, J.;  Liu, X. -Q. 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/03 chemotherapy regimen  epidermal growth factor receptors  exons  kinase inhibitors  mutation  phase 3 clinical trials  protein-tyrosine kinase inhibitor  tyrosine   Quaity of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC) 期刊论文 ANNALS OF ONCOLOGY, 2013, 卷号: 24, 期号: 6, 页码: 1615-1622 作者:  Chen, G.;  Feng, J.;  Zhou, C.*;  Wu, Y. -L.;  Liu, X. -Q. 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/03 chemotherapy  EGFR mutations  erlotinib  non-small-cell lung cancer (NSCLC)  quality of life (QoL)